

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of dendrite morphogenesis (GO:0050774) | 6.56020240 |
| 2 | peripheral nervous system neuron development (GO:0048935) | 5.80513520 |
| 3 | neuronal action potential propagation (GO:0019227) | 5.20009598 |
| 4 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 5.16939893 |
| 5 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 5.16939893 |
| 6 | neurofilament cytoskeleton organization (GO:0060052) | 4.94359804 |
| 7 | cell migration in hindbrain (GO:0021535) | 4.78701280 |
| 8 | detection of temperature stimulus (GO:0016048) | 4.70550157 |
| 9 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.52328907 |
| 10 | negative regulation of dendrite development (GO:2000171) | 4.47508008 |
| 11 | protein localization to endosome (GO:0036010) | 4.45449960 |
| 12 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.38126736 |
| 13 | cell adhesion mediated by integrin (GO:0033627) | 4.34536991 |
| 14 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.20168101 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 4.02688621 |
| 16 | vocalization behavior (GO:0071625) | 4.01114079 |
| 17 | membrane raft organization (GO:0031579) | 3.98688461 |
| 18 | serotonin receptor signaling pathway (GO:0007210) | 3.87391148 |
| 19 | neuronal action potential (GO:0019228) | 3.79325192 |
| 20 | positive regulation of macrophage differentiation (GO:0045651) | 3.78785941 |
| 21 | hypotonic response (GO:0006971) | 3.67807034 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.60848292 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 3.54499225 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 3.53621416 |
| 25 | membrane depolarization during action potential (GO:0086010) | 3.51306548 |
| 26 | inositol phosphate catabolic process (GO:0071545) | 3.49752437 |
| 27 | synaptic vesicle maturation (GO:0016188) | 3.42807324 |
| 28 | response to peptidoglycan (GO:0032494) | 3.42670800 |
| 29 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.41102627 |
| 30 | cellular extravasation (GO:0045123) | 3.34530702 |
| 31 | protein localization to synapse (GO:0035418) | 3.29793920 |
| 32 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.29694868 |
| 33 | innervation (GO:0060384) | 3.27145064 |
| 34 | positive regulation of leukocyte degranulation (GO:0043302) | 3.25559852 |
| 35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.25225709 |
| 36 | barbed-end actin filament capping (GO:0051016) | 3.23746112 |
| 37 | glutamate secretion (GO:0014047) | 3.19300735 |
| 38 | gamma-aminobutyric acid transport (GO:0015812) | 3.18758691 |
| 39 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.18735006 |
| 40 | substrate-dependent cell migration (GO:0006929) | 3.18715746 |
| 41 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.16866719 |
| 42 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15589881 |
| 43 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.15033037 |
| 44 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.12208923 |
| 45 | neurotransmitter secretion (GO:0007269) | 3.10873853 |
| 46 | response to acidic pH (GO:0010447) | 3.10367968 |
| 47 | regulation of macrophage cytokine production (GO:0010935) | 3.09823671 |
| 48 | proline transport (GO:0015824) | 3.07768766 |
| 49 | establishment of mitochondrion localization (GO:0051654) | 3.07465788 |
| 50 | regulation of synaptic vesicle transport (GO:1902803) | 3.04311953 |
| 51 | transferrin transport (GO:0033572) | 3.01820927 |
| 52 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.00608437 |
| 53 | hepatocyte apoptotic process (GO:0097284) | 3.00185918 |
| 54 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.99948499 |
| 55 | mesodermal cell differentiation (GO:0048333) | 2.98144858 |
| 56 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.94737370 |
| 57 | skin morphogenesis (GO:0043589) | 2.94040209 |
| 58 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.92650840 |
| 59 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.92257420 |
| 60 | thrombin receptor signaling pathway (GO:0070493) | 2.91296706 |
| 61 | regulation of leukocyte degranulation (GO:0043300) | 2.90971688 |
| 62 | pinocytosis (GO:0006907) | 2.90101862 |
| 63 | hemidesmosome assembly (GO:0031581) | 2.90084557 |
| 64 | regulation of relaxation of muscle (GO:1901077) | 2.87115804 |
| 65 | sphingosine metabolic process (GO:0006670) | 2.82773006 |
| 66 | stress fiber assembly (GO:0043149) | 2.82354706 |
| 67 | negative regulation of interleukin-17 production (GO:0032700) | 2.82088132 |
| 68 | response to laminar fluid shear stress (GO:0034616) | 2.82026170 |
| 69 | phagosome maturation (GO:0090382) | 2.81440063 |
| 70 | behavioral response to pain (GO:0048266) | 2.80941876 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 2.79725006 |
| 72 | granulocyte activation (GO:0036230) | 2.79703368 |
| 73 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78625407 |
| 74 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.78036786 |
| 75 | trivalent inorganic cation transport (GO:0072512) | 2.74329750 |
| 76 | ferric iron transport (GO:0015682) | 2.74329750 |
| 77 | protein localization to microtubule (GO:0035372) | 2.73811586 |
| 78 | neuromuscular process controlling posture (GO:0050884) | 2.73239597 |
| 79 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.73208074 |
| 80 | response to pain (GO:0048265) | 2.70720639 |
| 81 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.70437095 |
| 82 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.70437095 |
| 83 | germinal center formation (GO:0002467) | 2.68716837 |
| 84 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.68672580 |
| 85 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.68296320 |
| 86 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.66571010 |
| 87 | positive regulation of amino acid transport (GO:0051957) | 2.66210873 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 2.65756263 |
| 89 | glycosphingolipid catabolic process (GO:0046479) | 2.64984051 |
| 90 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.64011265 |
| 91 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.63665798 |
| 92 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.63367367 |
| 93 | histamine secretion (GO:0001821) | 2.63176686 |
| 94 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.62024131 |
| 95 | mitochondrion transport along microtubule (GO:0047497) | 2.62024131 |
| 96 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.61240526 |
| 97 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.60157994 |
| 98 | positive regulation of mast cell degranulation (GO:0043306) | 2.60157994 |
| 99 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.59312152 |
| 100 | synapse assembly (GO:0007416) | 2.57574058 |
| 101 | positive regulation of mitochondrial fission (GO:0090141) | 2.57270538 |
| 102 | regulation of mast cell activation (GO:0033003) | 2.57082516 |
| 103 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.56938842 |
| 104 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.56771197 |
| 105 | negative regulation of cation channel activity (GO:2001258) | 2.56706658 |
| 106 | negative regulation of monooxygenase activity (GO:0032769) | 2.55527746 |
| 107 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.55365963 |
| 108 | negative regulation of microtubule polymerization (GO:0031115) | 2.54928203 |
| 109 | regulation of metalloenzyme activity (GO:0048552) | 2.54183724 |
| 110 | negative regulation of membrane potential (GO:0045837) | 2.53968980 |
| 111 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.53103661 |
| 112 | cortical actin cytoskeleton organization (GO:0030866) | 2.52992957 |
| 113 | regulation of neuron projection regeneration (GO:0070570) | 2.51804920 |
| 114 | regulation of axon regeneration (GO:0048679) | 2.51804920 |
| 115 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.51365980 |
| 116 | neutrophil activation (GO:0042119) | 2.50959944 |
| 117 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.49405344 |
| 118 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.48378399 |
| 119 | membrane depolarization (GO:0051899) | 2.47594605 |
| 120 | response to muramyl dipeptide (GO:0032495) | 2.47093234 |
| 121 | angiogenesis involved in wound healing (GO:0060055) | 2.47081420 |
| 122 | exploration behavior (GO:0035640) | 2.46448325 |
| 123 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.45676655 |
| 124 | integrin-mediated signaling pathway (GO:0007229) | 2.45282399 |
| 125 | organelle transport along microtubule (GO:0072384) | 2.45010081 |
| 126 | apoptotic cell clearance (GO:0043277) | 2.44950405 |
| 127 | cellular response to vitamin D (GO:0071305) | 2.44108315 |
| 128 | leukocyte degranulation (GO:0043299) | 2.43121981 |
| 129 | action potential (GO:0001508) | 2.43113505 |
| 130 | B cell receptor signaling pathway (GO:0050853) | 2.41580509 |
| 131 | detection of molecule of bacterial origin (GO:0032490) | 2.41580092 |
| 132 | regulation of glutamate secretion (GO:0014048) | 2.41533739 |
| 133 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.40032159 |
| 134 | cellular response to ethanol (GO:0071361) | 2.39536052 |
| 135 | neurotransmitter transport (GO:0006836) | 2.39087764 |
| 136 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.38595963 |
| 137 | oligosaccharide catabolic process (GO:0009313) | 2.38252635 |
| 138 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.37357649 |
| 139 | positive regulation of muscle hypertrophy (GO:0014742) | 2.37357649 |
| 140 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.36795760 |
| 141 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.36700260 |
| 142 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.36626025 |
| 143 | regulation of cell communication by electrical coupling (GO:0010649) | 2.36167414 |
| 144 | phagocytosis, engulfment (GO:0006911) | 2.35120714 |
| 145 | myeloid cell activation involved in immune response (GO:0002275) | 2.34458732 |
| 146 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.34111216 |
| 147 | cellular copper ion homeostasis (GO:0006878) | 2.33297661 |
| 148 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.33211212 |
| 149 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.33171290 |
| 150 | macrophage activation involved in immune response (GO:0002281) | 2.32720802 |
| 151 | regulation of fever generation (GO:0031620) | 2.32294407 |
| 152 | vesicle transport along microtubule (GO:0047496) | 2.32070230 |
| 153 | response to progesterone (GO:0032570) | 2.31299541 |
| 154 | diol metabolic process (GO:0034311) | 2.30817472 |
| 155 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.30748847 |
| 156 | regulation of superoxide anion generation (GO:0032928) | 2.30667923 |
| 157 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.30150962 |
| 158 | clathrin coat assembly (GO:0048268) | 2.30091052 |
| 159 | negative regulation of heart rate (GO:0010459) | 2.29878730 |
| 160 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.29805741 |
| 161 | cell-substrate junction assembly (GO:0007044) | 2.29529968 |
| 162 | negative regulation of smooth muscle contraction (GO:0045986) | 2.29308103 |
| 163 | negative regulation of cell killing (GO:0031342) | 2.29194180 |
| 164 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.29194180 |
| 165 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.29173892 |
| 166 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.29163063 |
| 167 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.28876724 |
| 168 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.28876724 |
| 169 | positive regulation of B cell differentiation (GO:0045579) | 2.28658886 |
| 170 | decidualization (GO:0046697) | 2.28100274 |
| 171 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.27928700 |
| 172 | negative regulation of mast cell activation (GO:0033004) | 2.27810247 |
| 173 | positive regulation of regulated secretory pathway (GO:1903307) | 2.27747684 |
| 174 | establishment of endothelial barrier (GO:0061028) | 2.27132034 |
| 175 | synaptic vesicle transport (GO:0048489) | 2.27107156 |
| 176 | establishment of synaptic vesicle localization (GO:0097480) | 2.27107156 |
| 177 | glycolipid catabolic process (GO:0019377) | 2.27046391 |
| 178 | amino sugar catabolic process (GO:0046348) | 2.26999043 |
| 179 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.26587224 |
| 180 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.26571589 |
| 181 | positive regulation by symbiont of host defense response (GO:0052509) | 2.26320140 |
| 182 | modulation by symbiont of host defense response (GO:0052031) | 2.26320140 |
| 183 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.26320140 |
| 184 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.26320140 |
| 185 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.26320140 |
| 186 | modulation by symbiont of host immune response (GO:0052553) | 2.26320140 |
| 187 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.26167337 |
| 188 | negative regulation of anoikis (GO:2000811) | 2.25487518 |
| 189 | inositol phosphate dephosphorylation (GO:0046855) | 2.24521839 |
| 190 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.24521839 |
| 191 | regulation of protein heterodimerization activity (GO:0043497) | 2.24407341 |
| 192 | membrane repolarization (GO:0086009) | 2.24154104 |
| 193 | positive regulation of heat generation (GO:0031652) | 2.23558767 |
| 194 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.23042068 |
| 195 | endodermal cell differentiation (GO:0035987) | 2.22750972 |
| 196 | regulation of cell adhesion mediated by integrin (GO:0033628) | 2.22181949 |
| 197 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.22111129 |
| 198 | leukocyte aggregation (GO:0070486) | 2.21570067 |
| 199 | membrane protein ectodomain proteolysis (GO:0006509) | 2.21071823 |
| 200 | sprouting angiogenesis (GO:0002040) | 2.20133752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.91831461 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.90112439 |
| 3 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.65409266 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.35985785 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.30995605 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.96510665 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95378917 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.71100491 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.68858796 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.68216888 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.64813145 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.59653082 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.59281187 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.54777628 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.48824070 |
| 16 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.42849675 |
| 17 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.27423835 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.23786171 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.22839099 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.20058373 |
| 21 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.19264681 |
| 22 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.19264681 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.17771654 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.16151662 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.15816762 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.10880054 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.09960816 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09677127 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.08616393 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.08068823 |
| 31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.07991483 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00091250 |
| 33 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.00030993 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.00030993 |
| 35 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.99729175 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.99392967 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.99163461 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.98131965 |
| 39 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95103008 |
| 40 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.94728010 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.92031054 |
| 42 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.91762706 |
| 43 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.89995176 |
| 44 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.89022971 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88438072 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83565333 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.82668938 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82106925 |
| 49 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80496400 |
| 50 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.76236355 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74525227 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.72495494 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72216392 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71898280 |
| 55 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71166871 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.70502908 |
| 57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70204603 |
| 58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.68817963 |
| 59 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.68274993 |
| 60 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.68102920 |
| 61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.63066888 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.62076098 |
| 63 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60785902 |
| 64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60480253 |
| 65 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.60174041 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58753392 |
| 67 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58653341 |
| 68 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.58099286 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55452670 |
| 70 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.55330053 |
| 71 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.51675257 |
| 72 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51022001 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50083134 |
| 74 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.49849949 |
| 75 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.49702051 |
| 76 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49363737 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48814422 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48655003 |
| 79 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.48529716 |
| 80 | CJUN_26792858_Chip-Seq_BT549_Human | 1.47569592 |
| 81 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46052206 |
| 82 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.46041323 |
| 83 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45348273 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45192789 |
| 85 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.44967955 |
| 86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.43654539 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.41685189 |
| 88 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40920940 |
| 89 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40688777 |
| 90 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.40683370 |
| 91 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.40620091 |
| 92 | MYB_26560356_Chip-Seq_TH1_Human | 1.39486336 |
| 93 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39125345 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38597032 |
| 95 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37914597 |
| 96 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.36391104 |
| 97 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36366984 |
| 98 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35783424 |
| 99 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.35086159 |
| 100 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34163126 |
| 101 | MYC_22102868_ChIP-Seq_BL_Human | 1.33457193 |
| 102 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33191085 |
| 103 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.29927610 |
| 104 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28411448 |
| 105 | MAF_26560356_Chip-Seq_TH1_Human | 1.27163463 |
| 106 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26647564 |
| 107 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.26446795 |
| 108 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25808512 |
| 109 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25306358 |
| 110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25050128 |
| 111 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24810689 |
| 112 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24423825 |
| 113 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.24377896 |
| 114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24328549 |
| 115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.23716204 |
| 116 | JUN_21703547_ChIP-Seq_K562_Human | 1.22515986 |
| 117 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.22066121 |
| 118 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.21524278 |
| 119 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21334352 |
| 120 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21124425 |
| 121 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20447339 |
| 122 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.19556688 |
| 123 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18550710 |
| 124 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18139683 |
| 125 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17803681 |
| 126 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16876755 |
| 127 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.16860626 |
| 128 | KDM2B_26808549_Chip-Seq_REH_Human | 1.16696813 |
| 129 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16047206 |
| 130 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15770051 |
| 131 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14978265 |
| 132 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14465433 |
| 133 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14030475 |
| 134 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12285149 |
| 135 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10965756 |
| 136 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10770191 |
| 137 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10647037 |
| 138 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10162542 |
| 139 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09872082 |
| 140 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.08475179 |
| 141 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08395838 |
| 142 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07772351 |
| 143 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07672913 |
| 144 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07097456 |
| 145 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07037672 |
| 146 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06831332 |
| 147 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06419601 |
| 148 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06354071 |
| 149 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06041364 |
| 150 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04637958 |
| 151 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04489572 |
| 152 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03962983 |
| 153 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03558304 |
| 154 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03526749 |
| 155 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.03053935 |
| 156 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02916149 |
| 157 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02858869 |
| 158 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01819616 |
| 159 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01550887 |
| 160 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01550887 |
| 161 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01408786 |
| 162 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01392809 |
| 163 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00556983 |
| 164 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00429508 |
| 165 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99668809 |
| 166 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99178320 |
| 167 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99155646 |
| 168 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98979162 |
| 169 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.97313999 |
| 170 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97211430 |
| 171 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96383512 |
| 172 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96253801 |
| 173 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96028768 |
| 174 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95126370 |
| 175 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95126370 |
| 176 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94627575 |
| 177 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93962090 |
| 178 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.93842806 |
| 179 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93388741 |
| 180 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93079348 |
| 181 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93061755 |
| 182 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92453634 |
| 183 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92346714 |
| 184 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91837936 |
| 185 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90642042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 5.96103029 |
| 2 | MP0001986_abnormal_taste_sensitivity | 4.73581781 |
| 3 | MP0004270_analgesia | 3.92093671 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.83056203 |
| 5 | MP0002736_abnormal_nociception_after | 3.70885198 |
| 6 | MP0009046_muscle_twitch | 3.38683824 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 3.19512018 |
| 8 | MP0006276_abnormal_autonomic_nervous | 3.15829933 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 3.13517743 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 3.13337086 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 3.08639352 |
| 12 | MP0004858_abnormal_nervous_system | 2.90854321 |
| 13 | MP0002733_abnormal_thermal_nociception | 2.76368460 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.64139659 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.62561690 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.61525091 |
| 17 | MP0001970_abnormal_pain_threshold | 2.56830368 |
| 18 | MP0003880_abnormal_central_pattern | 2.55264361 |
| 19 | MP0006054_spinal_hemorrhage | 2.46719061 |
| 20 | MP0002064_seizures | 2.40628029 |
| 21 | MP0009745_abnormal_behavioral_response | 2.36231505 |
| 22 | MP0002272_abnormal_nervous_system | 2.35947974 |
| 23 | MP0004147_increased_porphyrin_level | 2.25142709 |
| 24 | MP0003950_abnormal_plasma_membrane | 2.23719007 |
| 25 | MP0003091_abnormal_cell_migration | 2.16111845 |
| 26 | MP0002067_abnormal_sensory_capabilities | 2.13111764 |
| 27 | MP0004947_skin_inflammation | 2.11779528 |
| 28 | MP0002184_abnormal_innervation | 2.08738829 |
| 29 | MP0002063_abnormal_learning/memory/cond | 2.06816673 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 1.96206447 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.92395945 |
| 32 | MP0002572_abnormal_emotion/affect_behav | 1.91646865 |
| 33 | MP0001853_heart_inflammation | 1.88452366 |
| 34 | MP0000685_abnormal_immune_system | 1.84866034 |
| 35 | MP0000858_altered_metastatic_potential | 1.79984457 |
| 36 | MP0003724_increased_susceptibility_to | 1.79860252 |
| 37 | MP0005023_abnormal_wound_healing | 1.79127554 |
| 38 | MP0003828_pulmonary_edema | 1.79056874 |
| 39 | MP0009840_abnormal_foam_cell | 1.76439118 |
| 40 | MP0000343_altered_response_to | 1.75770096 |
| 41 | MP0003279_aneurysm | 1.74201886 |
| 42 | MP0001188_hyperpigmentation | 1.73413965 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.72072439 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.71232447 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.70191824 |
| 46 | MP0008569_lethality_at_weaning | 1.68505737 |
| 47 | MP0003448_altered_tumor_morphology | 1.64694462 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.63017407 |
| 49 | MP0009278_abnormal_bone_marrow | 1.61913696 |
| 50 | MP0004510_myositis | 1.60311173 |
| 51 | MP0005451_abnormal_body_composition | 1.56808079 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.55105386 |
| 53 | MP0001486_abnormal_startle_reflex | 1.52634878 |
| 54 | MP0004811_abnormal_neuron_physiology | 1.51724302 |
| 55 | MP0002405_respiratory_system_inflammati | 1.51640092 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.48586251 |
| 57 | MP0005164_abnormal_response_to | 1.48062327 |
| 58 | MP0004142_abnormal_muscle_tone | 1.47886386 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.46740775 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.46334404 |
| 61 | MP0002822_catalepsy | 1.45049700 |
| 62 | MP0003787_abnormal_imprinting | 1.41960298 |
| 63 | MP0001835_abnormal_antigen_presentation | 1.38012034 |
| 64 | MP0001348_abnormal_lacrimal_gland | 1.36665621 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.35904733 |
| 66 | MP0005671_abnormal_response_to | 1.33057417 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.30103897 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.29478786 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.29478786 |
| 70 | MP0005423_abnormal_somatic_nervous | 1.29450078 |
| 71 | MP0005257_abnormal_intraocular_pressure | 1.29326022 |
| 72 | MP0001958_emphysema | 1.28192543 |
| 73 | MP0004924_abnormal_behavior | 1.27334416 |
| 74 | MP0005386_behavior/neurological_phenoty | 1.27334416 |
| 75 | MP0008260_abnormal_autophagy | 1.25923147 |
| 76 | MP0003075_altered_response_to | 1.25461905 |
| 77 | MP0000955_abnormal_spinal_cord | 1.25354642 |
| 78 | MP0003303_peritoneal_inflammation | 1.25325131 |
| 79 | MP0000372_irregular_coat_pigmentation | 1.24708592 |
| 80 | MP0002398_abnormal_bone_marrow | 1.24159128 |
| 81 | MP0001984_abnormal_olfaction | 1.23771558 |
| 82 | MP0005623_abnormal_meninges_morphology | 1.22024204 |
| 83 | MP0005165_increased_susceptibility_to | 1.19495691 |
| 84 | MP0000716_abnormal_immune_system | 1.18765104 |
| 85 | MP0001440_abnormal_grooming_behavior | 1.18445837 |
| 86 | MP0002557_abnormal_social/conspecific_i | 1.17787040 |
| 87 | MP0002751_abnormal_autonomic_nervous | 1.17762777 |
| 88 | MP0001849_ear_inflammation | 1.17745022 |
| 89 | MP0004883_abnormal_blood_vessel | 1.16653967 |
| 90 | MP0009764_decreased_sensitivity_to | 1.15305482 |
| 91 | MP0006082_CNS_inflammation | 1.14787288 |
| 92 | MP0004272_abnormal_basement_membrane | 1.14510104 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 1.13822271 |
| 94 | MP0000604_amyloidosis | 1.11580680 |
| 95 | MP0003879_abnormal_hair_cell | 1.11402810 |
| 96 | MP0003329_amyloid_beta_deposits | 1.11081735 |
| 97 | MP0000778_abnormal_nervous_system | 1.09608707 |
| 98 | MP0001845_abnormal_inflammatory_respons | 1.09374693 |
| 99 | MP0001905_abnormal_dopamine_level | 1.09371381 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 1.09199971 |
| 101 | MP0002722_abnormal_immune_system | 1.08964384 |
| 102 | MP0010155_abnormal_intestine_physiology | 1.08320996 |
| 103 | MP0002882_abnormal_neuron_morphology | 1.07494175 |
| 104 | MP0002006_tumorigenesis | 1.07148620 |
| 105 | MP0003045_fibrosis | 1.06688309 |
| 106 | MP0002066_abnormal_motor_capabilities/c | 1.06041643 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 1.03112865 |
| 108 | MP0001851_eye_inflammation | 1.02962989 |
| 109 | MP0000689_abnormal_spleen_morphology | 1.02786262 |
| 110 | MP0005171_absent_coat_pigmentation | 1.02346385 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 1.01366443 |
| 112 | MP0001915_intracranial_hemorrhage | 1.00343407 |
| 113 | MP0005000_abnormal_immune_tolerance | 1.00124894 |
| 114 | MP0004742_abnormal_vestibular_system | 0.99814988 |
| 115 | MP0002429_abnormal_blood_cell | 0.99513165 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.99331066 |
| 117 | MP0001542_abnormal_bone_strength | 0.98849915 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.96995417 |
| 119 | MP0000569_abnormal_digit_pigmentation | 0.96893039 |
| 120 | MP0002060_abnormal_skin_morphology | 0.94661709 |
| 121 | MP0003172_abnormal_lysosome_physiology | 0.94332130 |
| 122 | MP0002229_neurodegeneration | 0.93867049 |
| 123 | MP0001243_abnormal_dermal_layer | 0.93748117 |
| 124 | MP0002419_abnormal_innate_immunity | 0.92042869 |
| 125 | MP0001963_abnormal_hearing_physiology | 0.91643321 |
| 126 | MP0008469_abnormal_protein_level | 0.90246636 |
| 127 | MP0000920_abnormal_myelination | 0.89573356 |
| 128 | MP0001529_abnormal_vocalization | 0.88619177 |
| 129 | MP0000249_abnormal_blood_vessel | 0.87696950 |
| 130 | MP0005464_abnormal_platelet_physiology | 0.85825569 |
| 131 | MP0003122_maternal_imprinting | 0.85546269 |
| 132 | MP0005646_abnormal_pituitary_gland | 0.85399333 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.83989516 |
| 134 | MP0003795_abnormal_bone_structure | 0.83537658 |
| 135 | MP0005621_abnormal_cell_physiology | 0.83513202 |
| 136 | MP0003633_abnormal_nervous_system | 0.83300955 |
| 137 | MP0000703_abnormal_thymus_morphology | 0.83074251 |
| 138 | MP0001216_abnormal_epidermal_layer | 0.82143456 |
| 139 | MP0005166_decreased_susceptibility_to | 0.80663778 |
| 140 | MP0003634_abnormal_glial_cell | 0.79894787 |
| 141 | MP0009763_increased_sensitivity_to | 0.78015040 |
| 142 | MP0008004_abnormal_stomach_pH | 0.77733321 |
| 143 | MP0010386_abnormal_urinary_bladder | 0.77696526 |
| 144 | MP0003631_nervous_system_phenotype | 0.77498846 |
| 145 | MP0003646_muscle_fatigue | 0.76885577 |
| 146 | MP0005058_abnormal_lysosome_morphology | 0.76581115 |
| 147 | MP0002876_abnormal_thyroid_physiology | 0.75597709 |
| 148 | MP0001191_abnormal_skin_condition | 0.74903805 |
| 149 | MP0002723_abnormal_immune_serum | 0.74875218 |
| 150 | MP0009785_altered_susceptibility_to | 0.74777934 |
| 151 | MP0000733_abnormal_muscle_development | 0.73955600 |
| 152 | MP0003436_decreased_susceptibility_to | 0.73896444 |
| 153 | MP0005310_abnormal_salivary_gland | 0.73320949 |
| 154 | MP0001819_abnormal_immune_cell | 0.72868873 |
| 155 | MP0002420_abnormal_adaptive_immunity | 0.72489452 |
| 156 | MP0002452_abnormal_antigen_presenting | 0.71711512 |
| 157 | MP0002332_abnormal_exercise_endurance | 0.69596570 |
| 158 | MP0005387_immune_system_phenotype | 0.69445169 |
| 159 | MP0001790_abnormal_immune_system | 0.69445169 |
| 160 | MP0001800_abnormal_humoral_immune | 0.69078785 |
| 161 | MP0003866_abnormal_defecation | 0.68879701 |
| 162 | MP0002752_abnormal_somatic_nervous | 0.66494423 |
| 163 | MP0005174_abnormal_tail_pigmentation | 0.64884643 |
| 164 | MP0001502_abnormal_circadian_rhythm | 0.64681185 |
| 165 | MP0005645_abnormal_hypothalamus_physiol | 0.64617949 |
| 166 | MP0009697_abnormal_copulation | 0.62632259 |
| 167 | MP0008874_decreased_physiological_sensi | 0.61765246 |
| 168 | MP0005025_abnormal_response_to | 0.60442785 |
| 169 | MP0001270_distended_abdomen | 0.59182066 |
| 170 | MP0004484_altered_response_of | 0.55417285 |
| 171 | MP0004085_abnormal_heartbeat | 0.53590206 |
| 172 | MP0005535_abnormal_body_temperature | 0.53280685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.59410937 |
| 2 | Febrile seizures (HP:0002373) | 5.94285044 |
| 3 | Atonic seizures (HP:0010819) | 5.93323801 |
| 4 | Myokymia (HP:0002411) | 5.61627150 |
| 5 | Ulnar claw (HP:0001178) | 4.97808784 |
| 6 | Action tremor (HP:0002345) | 4.64585859 |
| 7 | Hypothermia (HP:0002045) | 4.41258301 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 4.36264094 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.36264094 |
| 10 | Focal seizures (HP:0007359) | 4.35570531 |
| 11 | Neuroendocrine neoplasm (HP:0100634) | 4.05028854 |
| 12 | Abnormal hair whorl (HP:0010721) | 4.01616114 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.92251561 |
| 14 | Pheochromocytoma (HP:0002666) | 3.89054446 |
| 15 | Absence seizures (HP:0002121) | 3.78577975 |
| 16 | Epileptic encephalopathy (HP:0200134) | 3.73072412 |
| 17 | Dialeptic seizures (HP:0011146) | 3.57581153 |
| 18 | Progressive inability to walk (HP:0002505) | 3.54849876 |
| 19 | T lymphocytopenia (HP:0005403) | 3.54338917 |
| 20 | Myocardial infarction (HP:0001658) | 3.34442630 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.27775314 |
| 22 | Spondylolisthesis (HP:0003302) | 3.21594059 |
| 23 | Failure to thrive in infancy (HP:0001531) | 3.18691057 |
| 24 | Termporal pattern (HP:0011008) | 3.18271039 |
| 25 | Insidious onset (HP:0003587) | 3.18271039 |
| 26 | Abnormality of T cell number (HP:0011839) | 3.08984769 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.02451447 |
| 28 | Eczematoid dermatitis (HP:0000976) | 2.97029151 |
| 29 | Neurofibrillary tangles (HP:0002185) | 2.95582432 |
| 30 | B lymphocytopenia (HP:0010976) | 2.94172963 |
| 31 | Abnormal platelet volume (HP:0011876) | 2.88252375 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.86492053 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.84756005 |
| 34 | Increased mean platelet volume (HP:0011877) | 2.84300397 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.76963575 |
| 36 | Upper motor neuron abnormality (HP:0002127) | 2.76693452 |
| 37 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.75360410 |
| 38 | Osteolytic defects of the hand bones (HP:0009699) | 2.75360410 |
| 39 | Arterial tortuosity (HP:0005116) | 2.75077688 |
| 40 | Abnormality of pain sensation (HP:0010832) | 2.72162791 |
| 41 | Impaired pain sensation (HP:0007328) | 2.72162791 |
| 42 | Premature rupture of membranes (HP:0001788) | 2.71781812 |
| 43 | Visual hallucinations (HP:0002367) | 2.70492304 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 2.70149294 |
| 45 | Recurrent viral infections (HP:0004429) | 2.68035711 |
| 46 | Abnormality of B cell number (HP:0010975) | 2.65409083 |
| 47 | Truncal ataxia (HP:0002078) | 2.65184791 |
| 48 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.61065357 |
| 49 | Gaze-evoked nystagmus (HP:0000640) | 2.61062412 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.60945343 |
| 51 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.59524485 |
| 52 | Petechiae (HP:0000967) | 2.57095406 |
| 53 | Vascular tortuosity (HP:0004948) | 2.56712486 |
| 54 | Fetal akinesia sequence (HP:0001989) | 2.54902834 |
| 55 | Abnormality of binocular vision (HP:0011514) | 2.52020388 |
| 56 | Diplopia (HP:0000651) | 2.52020388 |
| 57 | Supranuclear gaze palsy (HP:0000605) | 2.51058121 |
| 58 | Recurrent abscess formation (HP:0002722) | 2.48268860 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.47708999 |
| 60 | Impaired platelet aggregation (HP:0003540) | 2.45580723 |
| 61 | Abnormal platelet function (HP:0011869) | 2.45580723 |
| 62 | Poor suck (HP:0002033) | 2.45472826 |
| 63 | Submucous cleft hard palate (HP:0000176) | 2.42594237 |
| 64 | Limb dystonia (HP:0002451) | 2.40710723 |
| 65 | Prolonged bleeding time (HP:0003010) | 2.40252344 |
| 66 | Eosinophilia (HP:0001880) | 2.37021323 |
| 67 | Mutism (HP:0002300) | 2.36464013 |
| 68 | Autoamputation (HP:0001218) | 2.36461680 |
| 69 | Atrophic scars (HP:0001075) | 2.36164345 |
| 70 | Cellulitis (HP:0100658) | 2.34812042 |
| 71 | Epistaxis (HP:0000421) | 2.34243698 |
| 72 | Subacute progressive viral hepatitis (HP:0006572) | 2.33917703 |
| 73 | Hypoplasia of the thymus (HP:0000778) | 2.29992416 |
| 74 | Granulocytopenia (HP:0001913) | 2.29320471 |
| 75 | Thick nail (HP:0001805) | 2.29176329 |
| 76 | Scanning speech (HP:0002168) | 2.28340276 |
| 77 | Abnormal eating behavior (HP:0100738) | 2.28088294 |
| 78 | Bradycardia (HP:0001662) | 2.27938474 |
| 79 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.27801843 |
| 80 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27325410 |
| 81 | Disinhibition (HP:0000734) | 2.25932455 |
| 82 | Spontaneous hematomas (HP:0007420) | 2.22990902 |
| 83 | Axonal loss (HP:0003447) | 2.21281843 |
| 84 | Stomatitis (HP:0010280) | 2.19895734 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19424079 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19424079 |
| 87 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19424079 |
| 88 | Aortic dissection (HP:0002647) | 2.19028763 |
| 89 | Inability to walk (HP:0002540) | 2.17476350 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 2.17065070 |
| 91 | Polyphagia (HP:0002591) | 2.16520838 |
| 92 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.15851420 |
| 93 | Hepatosplenomegaly (HP:0001433) | 2.14610071 |
| 94 | Mucopolysacchariduria (HP:0008155) | 2.14232716 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.14232716 |
| 96 | Loss of speech (HP:0002371) | 2.14207943 |
| 97 | Viral hepatitis (HP:0006562) | 2.14144744 |
| 98 | Combined immunodeficiency (HP:0005387) | 2.13233249 |
| 99 | Steppage gait (HP:0003376) | 2.12056274 |
| 100 | Abnormality of the vocal cords (HP:0008777) | 2.11294787 |
| 101 | Recurrent bacterial skin infections (HP:0005406) | 2.09997395 |
| 102 | Foot dorsiflexor weakness (HP:0009027) | 2.09196326 |
| 103 | Akinesia (HP:0002304) | 2.07687399 |
| 104 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.06396382 |
| 105 | Pustule (HP:0200039) | 2.05974918 |
| 106 | Spastic gait (HP:0002064) | 2.04984894 |
| 107 | Ankle clonus (HP:0011448) | 2.04766523 |
| 108 | Hypoplasia of the brainstem (HP:0002365) | 2.03929197 |
| 109 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.03929197 |
| 110 | Aortic aneurysm (HP:0004942) | 2.03890596 |
| 111 | Urinary urgency (HP:0000012) | 2.03405314 |
| 112 | Thyroid carcinoma (HP:0002890) | 2.02175434 |
| 113 | Menorrhagia (HP:0000132) | 2.01739017 |
| 114 | Glomerulopathy (HP:0100820) | 2.00064854 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 1.99174619 |
| 116 | Generalized hypotonia (HP:0001290) | 1.98280838 |
| 117 | Lower limb asymmetry (HP:0100559) | 1.97844450 |
| 118 | Leukocytosis (HP:0001974) | 1.97143556 |
| 119 | Distal lower limb amyotrophy (HP:0008944) | 1.96769624 |
| 120 | Fatigue (HP:0012378) | 1.96103519 |
| 121 | Protrusio acetabuli (HP:0003179) | 1.95613038 |
| 122 | Purpura (HP:0000979) | 1.94766083 |
| 123 | Abnormality of T cells (HP:0002843) | 1.93778217 |
| 124 | Abnormality of oral frenula (HP:0000190) | 1.93121118 |
| 125 | Abnormality of the corticospinal tract (HP:0002492) | 1.92880797 |
| 126 | Meningitis (HP:0001287) | 1.92416139 |
| 127 | Dysautonomia (HP:0002459) | 1.91992811 |
| 128 | Dilatation of the ascending aorta (HP:0005111) | 1.91838503 |
| 129 | Myositis (HP:0100614) | 1.91426305 |
| 130 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91322111 |
| 131 | Vertebral compression fractures (HP:0002953) | 1.90542300 |
| 132 | Increased cerebral lipofuscin (HP:0011813) | 1.89830530 |
| 133 | Spinal canal stenosis (HP:0003416) | 1.88621910 |
| 134 | Mitral stenosis (HP:0001718) | 1.86917244 |
| 135 | Tetraparesis (HP:0002273) | 1.86466704 |
| 136 | Recurrent skin infections (HP:0001581) | 1.84337910 |
| 137 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.83297808 |
| 138 | Orchitis (HP:0100796) | 1.83268983 |
| 139 | Severe combined immunodeficiency (HP:0004430) | 1.82926936 |
| 140 | Apathy (HP:0000741) | 1.82839469 |
| 141 | Abnormality of the foot musculature (HP:0001436) | 1.82394754 |
| 142 | Hammertoe (HP:0001765) | 1.81638699 |
| 143 | Spinal cord lesions (HP:0100561) | 1.81078047 |
| 144 | Syringomyelia (HP:0003396) | 1.81078047 |
| 145 | Oligomenorrhea (HP:0000876) | 1.80114412 |
| 146 | Osteomyelitis (HP:0002754) | 1.79229825 |
| 147 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.79206410 |
| 148 | Recurrent cutaneous fungal infections (HP:0011370) | 1.79206410 |
| 149 | Broad face (HP:0000283) | 1.79066704 |
| 150 | Delayed gross motor development (HP:0002194) | 1.78882202 |
| 151 | Wormian bones (HP:0002645) | 1.78188621 |
| 152 | Narrow nasal bridge (HP:0000446) | 1.77806870 |
| 153 | Global brain atrophy (HP:0002283) | 1.76782062 |
| 154 | Hyperventilation (HP:0002883) | 1.76667383 |
| 155 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76067848 |
| 156 | Chronic obstructive pulmonary disease (HP:0006510) | 1.75885416 |
| 157 | Obstructive lung disease (HP:0006536) | 1.75885416 |
| 158 | Milia (HP:0001056) | 1.75161862 |
| 159 | Depression (HP:0000716) | 1.74873308 |
| 160 | Esotropia (HP:0000565) | 1.74842225 |
| 161 | Psychosis (HP:0000709) | 1.73882956 |
| 162 | Abnormality of eosinophils (HP:0001879) | 1.73575111 |
| 163 | Optic neuritis (HP:0100653) | 1.73565593 |
| 164 | Retrobulbar optic neuritis (HP:0100654) | 1.73565593 |
| 165 | Amyloidosis (HP:0011034) | 1.73476810 |
| 166 | Cerebral hemorrhage (HP:0001342) | 1.73140604 |
| 167 | Gingival bleeding (HP:0000225) | 1.71723747 |
| 168 | Absent frontal sinuses (HP:0002688) | 1.70074575 |
| 169 | Neuronal loss in central nervous system (HP:0002529) | 1.69963465 |
| 170 | Pulmonary infiltrates (HP:0002113) | 1.69329735 |
| 171 | Mediastinal lymphadenopathy (HP:0100721) | 1.69311619 |
| 172 | Decreased motor nerve conduction velocity (HP:0003431) | 1.68945951 |
| 173 | Hypercortisolism (HP:0001578) | 1.67884875 |
| 174 | Slow saccadic eye movements (HP:0000514) | 1.67652322 |
| 175 | Decreased muscle mass (HP:0003199) | 1.67293096 |
| 176 | Distal sensory impairment (HP:0002936) | 1.65782018 |
| 177 | Aqueductal stenosis (HP:0002410) | 1.65190526 |
| 178 | Anxiety (HP:0000739) | 1.65181869 |
| 179 | Acute necrotizing encephalopathy (HP:0006965) | 1.64427668 |
| 180 | Dysmetria (HP:0001310) | 1.63686161 |
| 181 | Amblyopia (HP:0000646) | 1.63059412 |
| 182 | Diminished motivation (HP:0000745) | 1.62914382 |
| 183 | Postural tremor (HP:0002174) | 1.62077243 |
| 184 | Specific learning disability (HP:0001328) | 1.60528881 |
| 185 | Agitation (HP:0000713) | 1.59513873 |
| 186 | Heterochromia iridis (HP:0001100) | 1.59097742 |
| 187 | Absent speech (HP:0001344) | 1.58956580 |
| 188 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.58612287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.86878724 |
| 2 | IRAK3 | 3.81403577 |
| 3 | MAP3K12 | 3.69354184 |
| 4 | SIK3 | 3.65897158 |
| 5 | MINK1 | 3.32831631 |
| 6 | NTRK3 | 3.26475988 |
| 7 | MAP2K7 | 2.82813884 |
| 8 | TGFBR2 | 2.70558435 |
| 9 | MAP3K3 | 2.35806258 |
| 10 | MAP3K4 | 2.19652967 |
| 11 | SGK2 | 2.07822867 |
| 12 | LATS2 | 1.95765254 |
| 13 | STK10 | 1.92028524 |
| 14 | MST1R | 1.87601807 |
| 15 | MAP3K9 | 1.86739555 |
| 16 | RIPK4 | 1.85365819 |
| 17 | MAP2K3 | 1.84711526 |
| 18 | CAMKK2 | 1.82825639 |
| 19 | TTN | 1.81796745 |
| 20 | NTRK1 | 1.77706984 |
| 21 | MAP3K14 | 1.77248668 |
| 22 | NEK9 | 1.74580146 |
| 23 | PAK4 | 1.72057264 |
| 24 | PRPF4B | 1.65426839 |
| 25 | MAP2K4 | 1.63428717 |
| 26 | PDGFRA | 1.61845982 |
| 27 | EPHB1 | 1.59431070 |
| 28 | GRK5 | 1.58545002 |
| 29 | GRK7 | 1.58399257 |
| 30 | ARAF | 1.56273739 |
| 31 | MATK | 1.55930709 |
| 32 | MET | 1.54985820 |
| 33 | SGK223 | 1.54755189 |
| 34 | SGK494 | 1.54755189 |
| 35 | MAPK13 | 1.54181614 |
| 36 | LATS1 | 1.49990017 |
| 37 | MARK1 | 1.49039983 |
| 38 | TXK | 1.48186095 |
| 39 | BLK | 1.47664915 |
| 40 | STK24 | 1.44353761 |
| 41 | EPHA2 | 1.44009558 |
| 42 | SGK3 | 1.43849161 |
| 43 | NME2 | 1.43027516 |
| 44 | CSK | 1.40022561 |
| 45 | LIMK1 | 1.35673568 |
| 46 | PLK2 | 1.35206071 |
| 47 | YES1 | 1.34047051 |
| 48 | ERN1 | 1.29154538 |
| 49 | STK38 | 1.28367706 |
| 50 | KIT | 1.27496604 |
| 51 | ERBB4 | 1.26956594 |
| 52 | TESK1 | 1.26232965 |
| 53 | TESK2 | 1.25692382 |
| 54 | RPS6KA2 | 1.25151895 |
| 55 | BTK | 1.23568220 |
| 56 | CSF1R | 1.22491543 |
| 57 | CDK6 | 1.20797577 |
| 58 | FES | 1.18865805 |
| 59 | TAOK2 | 1.15518419 |
| 60 | BMPR2 | 1.11951227 |
| 61 | TRIM28 | 1.11243553 |
| 62 | TNK2 | 1.08910128 |
| 63 | PTK2 | 1.08179102 |
| 64 | TRPM7 | 1.07438983 |
| 65 | PTK2B | 1.05360838 |
| 66 | CAMK1D | 1.03684901 |
| 67 | MYLK | 1.03675823 |
| 68 | BCR | 1.01368126 |
| 69 | ADRBK2 | 0.98530323 |
| 70 | HCK | 0.98352931 |
| 71 | BMPR1B | 0.98004832 |
| 72 | KSR2 | 0.97972308 |
| 73 | CAMKK1 | 0.95761218 |
| 74 | SCYL2 | 0.94687359 |
| 75 | FLT3 | 0.94601758 |
| 76 | PIK3CG | 0.92396046 |
| 77 | NTRK2 | 0.91589773 |
| 78 | CLK1 | 0.90413439 |
| 79 | CDK8 | 0.89920645 |
| 80 | PRKCH | 0.88431432 |
| 81 | PAK2 | 0.88145712 |
| 82 | LMTK2 | 0.87572728 |
| 83 | PIM2 | 0.87480878 |
| 84 | SYK | 0.87437735 |
| 85 | TSSK6 | 0.86939008 |
| 86 | TYK2 | 0.86265139 |
| 87 | PRKCG | 0.86167055 |
| 88 | PDGFRB | 0.85182759 |
| 89 | FGR | 0.82204738 |
| 90 | CDK5 | 0.81628285 |
| 91 | ABL2 | 0.78700781 |
| 92 | WNK1 | 0.78653068 |
| 93 | AKT3 | 0.77643872 |
| 94 | BMX | 0.74603580 |
| 95 | ZAP70 | 0.73787658 |
| 96 | PRKCE | 0.73617808 |
| 97 | MAPKAPK3 | 0.73160722 |
| 98 | SIK2 | 0.71699670 |
| 99 | RET | 0.70030031 |
| 100 | CDC42BPA | 0.66287842 |
| 101 | IKBKB | 0.65762242 |
| 102 | MAP2K1 | 0.65715015 |
| 103 | EPHA3 | 0.65141549 |
| 104 | SMG1 | 0.64311064 |
| 105 | CAMK1G | 0.63409764 |
| 106 | HIPK2 | 0.61434089 |
| 107 | MAPKAPK2 | 0.61235145 |
| 108 | MELK | 0.60547073 |
| 109 | MAP3K8 | 0.60414440 |
| 110 | MAP3K13 | 0.58821482 |
| 111 | TBK1 | 0.58588067 |
| 112 | KSR1 | 0.58293199 |
| 113 | GRK6 | 0.56743251 |
| 114 | ICK | 0.54947675 |
| 115 | DAPK1 | 0.54794483 |
| 116 | ADRBK1 | 0.54264760 |
| 117 | MAP4K1 | 0.53476786 |
| 118 | IRAK2 | 0.53307112 |
| 119 | CAMK2A | 0.52256507 |
| 120 | MARK3 | 0.51583821 |
| 121 | MAP3K6 | 0.51574295 |
| 122 | LCK | 0.50771531 |
| 123 | RPS6KL1 | 0.50594794 |
| 124 | RPS6KC1 | 0.50594794 |
| 125 | BRAF | 0.50369589 |
| 126 | TNIK | 0.50312397 |
| 127 | LYN | 0.48883310 |
| 128 | GSK3A | 0.47788789 |
| 129 | DDR2 | 0.47702566 |
| 130 | MAP3K2 | 0.46435268 |
| 131 | IRAK1 | 0.45516005 |
| 132 | RPS6KA6 | 0.45281389 |
| 133 | DYRK2 | 0.45258651 |
| 134 | MAP3K1 | 0.45108694 |
| 135 | RPS6KB1 | 0.44948902 |
| 136 | ABL1 | 0.44341975 |
| 137 | MAPK11 | 0.44291466 |
| 138 | FGFR3 | 0.43888715 |
| 139 | PAK6 | 0.43737846 |
| 140 | MST4 | 0.42801461 |
| 141 | MAPKAPK5 | 0.41568790 |
| 142 | PRKG2 | 0.41277285 |
| 143 | PHKG2 | 0.40946737 |
| 144 | PHKG1 | 0.40946737 |
| 145 | MUSK | 0.40558030 |
| 146 | ITK | 0.38929517 |
| 147 | CAMK2G | 0.38511293 |
| 148 | STK3 | 0.38392262 |
| 149 | BRSK1 | 0.37494208 |
| 150 | CCNB1 | 0.37149851 |
| 151 | PDK1 | 0.36596128 |
| 152 | IKBKE | 0.36486415 |
| 153 | JAK1 | 0.36471139 |
| 154 | CDK14 | 0.34195783 |
| 155 | IRAK4 | 0.33587682 |
| 156 | ROCK2 | 0.31945643 |
| 157 | DAPK2 | 0.31893543 |
| 158 | CDK18 | 0.31882762 |
| 159 | TEC | 0.31645684 |
| 160 | MOS | 0.29455495 |
| 161 | JAK3 | 0.28879764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.38327267 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.46036268 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.25285806 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.10808596 |
| 5 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.86933896 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.83919785 |
| 7 | Taste transduction_Homo sapiens_hsa04742 | 1.83665659 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82692239 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.79057555 |
| 10 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.70754885 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.67598116 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.65030710 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.64673676 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58963087 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.57223612 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.56362995 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.53922135 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53848031 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.53774130 |
| 20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.52780954 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51618699 |
| 22 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.51612115 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.51431080 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.51220903 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.50951624 |
| 26 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.47584464 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.47287276 |
| 28 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.44446888 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.44275786 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39562967 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.38164970 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.37694627 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.37261392 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36325573 |
| 35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.36072587 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.34368730 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.30789143 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.30700027 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29717010 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.24315623 |
| 41 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22391622 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.20954575 |
| 43 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20857201 |
| 44 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.17083106 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.17029619 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16546674 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.16186053 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15397244 |
| 49 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.15196861 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14126287 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 1.13967856 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 1.13562541 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 1.13137998 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11868015 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.09040832 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08971907 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 1.08760715 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.08069938 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07403554 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 1.07284512 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 1.06767934 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06282548 |
| 63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05650592 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05544899 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04332550 |
| 66 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03925562 |
| 67 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.01967826 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 1.01822967 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98365050 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97858812 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97510292 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97014654 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.96398923 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96341840 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94036290 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92365881 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92093373 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91624463 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91614617 |
| 80 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89331119 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88496382 |
| 82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.88479915 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87386038 |
| 84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85182331 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83374088 |
| 86 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.82934922 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82819782 |
| 88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82368730 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.82043551 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.81823242 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.81747087 |
| 92 | Asthma_Homo sapiens_hsa05310 | 0.80109718 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.80038616 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79450827 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.78687055 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77993932 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.77734354 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77639440 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77388657 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.76137877 |
| 101 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76114714 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76023262 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.74813897 |
| 104 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74020622 |
| 105 | Shigellosis_Homo sapiens_hsa05131 | 0.73591603 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.73443757 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73019523 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72371209 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71763158 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70369088 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69962720 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68286466 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.67557850 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67298271 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67004955 |
| 116 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65608652 |
| 117 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.64283159 |
| 118 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63741150 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63490438 |
| 120 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62655299 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62328910 |
| 122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61833542 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61776910 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61655011 |
| 125 | Gap junction_Homo sapiens_hsa04540 | 0.60541622 |
| 126 | Pathways in cancer_Homo sapiens_hsa05200 | 0.60389634 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59488468 |
| 128 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58745842 |
| 129 | Cocaine addiction_Homo sapiens_hsa05030 | 0.58290965 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.58261814 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57581836 |
| 132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56944094 |
| 133 | Influenza A_Homo sapiens_hsa05164 | 0.56244926 |
| 134 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55749683 |
| 135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55640938 |
| 136 | Axon guidance_Homo sapiens_hsa04360 | 0.55152566 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55077953 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54385639 |
| 139 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54273949 |
| 140 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.54092397 |
| 141 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53432315 |
| 142 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53420067 |
| 143 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53116663 |
| 144 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53061608 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53040012 |
| 146 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52962818 |
| 147 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51852310 |
| 148 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51552131 |
| 149 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51476814 |
| 150 | Prostate cancer_Homo sapiens_hsa05215 | 0.50731621 |

